• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两个相隔较远的催化位点负责 C2c2 RNase 活性。

Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities.

机构信息

Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

Cell. 2017 Jan 12;168(1-2):121-134.e12. doi: 10.1016/j.cell.2016.12.031.

DOI:10.1016/j.cell.2016.12.031
PMID:28086085
Abstract

C2c2, the effector of type VI CRISPR-Cas systems, has two RNase activities-one for cutting its RNA target and the other for processing the CRISPR RNA (crRNA). Here, we report the structures of Leptotrichia shahii C2c2 in its crRNA-free and crRNA-bound states. While C2c2 has a bilobed structure reminiscent of all other Class 2 effectors, it also exhibits different structural characteristics. It contains the REC lobe with a Helical-1 domain and the NUC lobe with two HEPN domains. The two RNase catalytic pockets responsible for cleaving pre-crRNA and target RNA are independently located on Helical-1 and HEPN domains, respectively. crRNA binding induces significant conformational changes that are likely to stabilize crRNA binding and facilitate target RNA recognition. These structures provide important insights into the molecular mechanism of dual RNase activities of C2c2 and establish a framework for its future engineering as a RNA editing tool.

摘要

C2c2 是 VI 型 CRISPR-Cas 系统的效应蛋白,具有两种 RNase 活性——一种用于切割其 RNA 靶标,另一种用于加工 CRISPR RNA(crRNA)。在这里,我们报告了 Leptotrichia shahii C2c2 在无 crRNA 和结合 crRNA 状态下的结构。虽然 C2c2 具有类似于所有其他 2 类效应物的双叶结构,但它也表现出不同的结构特征。它包含具有螺旋-1 结构域的 REC 叶和具有两个 HEPN 结构域的 NUC 叶。负责切割 pre-crRNA 和靶 RNA 的两个 RNase 催化口袋分别位于螺旋-1 和 HEPN 结构域上。crRNA 结合诱导了显著的构象变化,这可能稳定 crRNA 的结合并促进靶 RNA 的识别。这些结构为 C2c2 的双 RNase 活性的分子机制提供了重要的见解,并为其作为 RNA 编辑工具的未来工程奠定了框架。

相似文献

1
Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities.两个相隔较远的催化位点负责 C2c2 RNase 活性。
Cell. 2017 Jan 12;168(1-2):121-134.e12. doi: 10.1016/j.cell.2016.12.031.
2
The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.Cas13a 介导的 RNA 引导的 RNA 切割的分子结构
Cell. 2017 Aug 10;170(4):714-726.e10. doi: 10.1016/j.cell.2017.06.050. Epub 2017 Jul 27.
3
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.CRISPR-C2c2的两种不同核糖核酸酶活性可实现引导RNA加工和RNA检测。
Nature. 2016 Oct 13;538(7624):270-273. doi: 10.1038/nature19802. Epub 2016 Sep 26.
4
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.C2c2是一种单组分可编程的RNA引导的RNA靶向CRISPR效应蛋白。
Science. 2016 Aug 5;353(6299):aaf5573. doi: 10.1126/science.aaf5573. Epub 2016 Jun 2.
5
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.多种2类CRISPR-Cas系统的发现与功能表征
Mol Cell. 2015 Nov 5;60(3):385-97. doi: 10.1016/j.molcel.2015.10.008. Epub 2015 Oct 22.
6
Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.Cas13 包含的 VI 型 CRISPR-Cas 系统靶向 RNA 的分子机制。
J Mol Biol. 2019 Jan 4;431(1):66-87. doi: 10.1016/j.jmb.2018.06.029. Epub 2018 Jun 22.
7
Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d.两个 HEPN 结构域决定 Cas13d 的 CRISPR RNA 成熟和靶标切割。
Nat Commun. 2019 Jun 11;10(1):2544. doi: 10.1038/s41467-019-10507-3.
8
Composition and Diversity of CRISPR-Cas13a Systems in the Genus .属中CRISPR-Cas13a系统的组成与多样性
Front Microbiol. 2019 Dec 10;10:2838. doi: 10.3389/fmicb.2019.02838. eCollection 2019.
9
Structural Basis for the Ribonuclease Activity of a Thermostable CRISPR-Cas13a from Thermoclostridium caenicola.热纤梭菌 Cas13a 核糖核酸酶活性的结构基础
J Mol Biol. 2023 Sep 1;435(17):168197. doi: 10.1016/j.jmb.2023.168197. Epub 2023 Jul 11.
10
Structural and biochemical insights into CRISPR RNA processing by the Cas5c ribonuclease SMU1763 from Streptococcus mutans.结构和生化研究揭示了变形链球菌 Cas5c 核糖核酸酶 SMU1763 对 CRISPR RNA 的加工机制。
J Biol Chem. 2021 Nov;297(5):101251. doi: 10.1016/j.jbc.2021.101251. Epub 2021 Sep 28.

引用本文的文献

1
Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease.用于中枢神经系统疾病的腺相关病毒介导的基因编辑疗法的趋势与挑战:对神经退行性疾病的启示
Mol Ther Nucleic Acids. 2025 Jul 17;36(3):102635. doi: 10.1016/j.omtn.2025.102635. eCollection 2025 Sep 9.
2
CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook.CRISPR/Cas技术在胰腺癌研究与治疗中的应用:最新进展与未来展望
Discov Oncol. 2025 Aug 11;16(1):1530. doi: 10.1007/s12672-025-03383-5.
3
Decoding RNA-Protein Interactions: Methodological Advances and Emerging Challenges.
解码RNA-蛋白质相互作用:方法学进展与新出现的挑战
Adv Genet (Hoboken). 2025 May 12;6(2):2500011. doi: 10.1002/ggn2.202500011. eCollection 2025 Jun.
4
A review on the mechanism and potential diagnostic application of CRISPR/Cas13a system.CRISPR/Cas13a系统的作用机制及其潜在诊断应用综述
Mamm Genome. 2025 Jun 24. doi: 10.1007/s00335-025-10143-x.
5
LbuCas13a directly targets DNA and elicits strong trans-cleavage activity.LbuCas13a直接靶向DNA并引发强烈的反式切割活性。
Nat Biomed Eng. 2025 Jun 20. doi: 10.1038/s41551-025-01424-6.
6
New hope and promise with CRISPR-Cas9 technology for the treatment of HIV.CRISPR-Cas9技术为治疗艾滋病带来新希望与前景。
Funct Integr Genomics. 2025 May 24;25(1):108. doi: 10.1007/s10142-025-01613-1.
7
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review).用于RNA靶向和编辑的CRISPR/Cas13系统的结构和功能方面的最新进展:癌症管理的下一代工具(综述)
Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5748. Epub 2025 May 9.
8
Current updates regarding biogenesis, functions and dysregulation of microRNAs in cancer: Innovative approaches for detection using CRISPR/Cas13‑based platforms (Review).癌症中微小RNA的生物发生、功能及失调的最新进展:基于CRISPR/Cas13平台的创新检测方法(综述)
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5531. Epub 2025 Apr 17.
9
CRISPR RNA binding drives structural ordering that primes Cas7-11 for target cleavage.CRISPR RNA结合驱动结构排序,为Cas7-11进行靶标切割做好准备。
Nucleic Acids Res. 2025 Apr 10;53(7). doi: 10.1093/nar/gkaf271.
10
Structural insights into RNA-guided RNA editing by the Cas13b-ADAR2 complex.Cas13b-ADAR2复合物对RNA引导的RNA编辑的结构见解。
Nat Struct Mol Biol. 2025 Apr 11. doi: 10.1038/s41594-025-01529-1.